Corporate Members

BÜHLMANN Laboratories AG

BUHLMANNWhat makes BÜHLMANN unique in the world of diagnostics? We have asked our customers, distributors and employees. Their answers can be symbolized up in the mascot of BÜHLMANN, the Saint Bernard Dogs, as they accompany us since more than 35 years. Saint Bernard dogs are unique, reliable and independent. And so is BÜHLMANN.

BÜHLMANN is proud to offer unique products and to set “gold standards” in the market with a series of our products in different fields. BÜHLMANN for example offers the only quantitative Calprotecin Assay – the Quantum Blue® Calprotectin. Together with its Calprotecin ELISA, BÜHLMANN sets new standards in the IBD diagnosis. Other unique “gold standards” are the BÜHLMANN Flow CAST® Product group in Basophil Activation Testing, or the BÜHLMANN GanglioCombi® Products, the only screening ELISAs for anti-Ganglioside testing. With third party companies,BÜHLMANN started its activities in molecular diagnostics five years ago.

Quality is not just a statement, but part of our commitment. The Management System is ISO 9001:2008 and 13485:2003 certified and the products are manufactured according to GMP standards. BÜHLMANN staff is continuously trained, as well as distributors and, individually, customers. BÜHLMANN is known for the outstanding quality of its products, its excellent after sales services and a worldwide availability through a network of highly qualified distributors.

BÜHLMANN is a fully independent, medium sized and family owned Swiss company. The company was founded in 1976 and has continuously developed over the years. Sister companies have been established in Austria (BUHLMANN in Austria GmbH) in 1996, in France (BUHLMANN France SAS) in 2002 and in Italy (BUHLMANN Italia srl) in 2009. Since 2005, BÜHLMANN products are directly distributed in Germany.

http://www.buhlmannlabs.ch/


 

 

SOCIETY

LAST NAME

FIRST NAME

ACTIVITIES

1

Bühlmann Laboratories

Buehlmann

Roland

Pharma/biotech

2

Galderma

Osman -Ponchet

Hanan

Pharma

3

GSK

Antoun

Zeina

Pharma

4

IPSEN

Thurieau

Christophe

Pharma

5

Novartis

Pallaud

Celine

Pharma

6

Roche Pharma

Funk

Christoph

Pharma

7

Sanofi Aventis

Sanderink

Gérard

Pharma

8

Teva

Grossman

Iris

Pharma

9

Laboratoires réunis

Weber

Bernard

Biotech

10

Thermo Fisher Scientific

Jacobs

Peter

Biotech

11

Luminex

Van Aarle

Pierre

Biotech

12

Randox

Lamont

John

Biotech

13

Roche Diagnostics

Jordan

Bruce

Biotech

14

Stabiligen

Siest

Jean-Pascal

Biotech

15

Eugenomic

Sabater

Juan

Biotech

16

Degruyter

Jahnke

Heike

IT

17

HMG Systems Engineering GmbH

Munoz-Galeano

Herna

IT

18

Genomatix

May

Klaus

IT

19

 Prahealthsciences

Purchase

Andrew

 Pharma

20

Translational Software                 

HACHAD             

RULE

Houda           

Don

IT                      

21

Abomics

Forsstrom

Jari

IT

 22

 Agena Bioscience

 Kasper

Dagmar 

Biotech 

 

 

 

Documents
ESPT Corporate Members Meeting, Santorini, Greece (September 26th, 2014)
ESPT Corporate Members Meeting, Lisbon, Portugal (September 28th, 2013)
ESPT Corporate Members meeting, Santorini, Greece (September 30th and October 1st 2012)